• Activity INFORMATION

  Overview

  In a podcast-style discussion, Mike Corvino, PharmD, and Cole Swanson, PharmD review the new AFib management guidelines published in 2023. AFib is the most sustained common arrhythmia and incidence in the US is increasing. Pharmacists and nurses regularly encounter patients with AFib who are at risk for complications. It is important that pharmacists and nurses understand the appropriate use of medications used to manage AFib and know how to identify patients who can benefit from them. This session explores these topics, focusing on how this information can best be incorporated into daily medical practice.

  Access the original podcast here.

   

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the different stages of AFib including the pre-detection period

  Recognize patients who could benefit from non-pharmacologic options such as catheter ablation

  Identify key updates from the previous AFib guideline

  Identify risk stratification tools used to identify patients indicated for anticoagulation

  Cite modifiable risk factors to prevent onset, progression, and adverse outcomes related to AFib

  Nurse

  Identify key updates from the previous AFib guideline

  Cite modifiable risk factors to prevent onset, progression, and adverse outcomes related to AFib

  Identify risk stratification tools used to identify patients indicated for anticoagulation

  Recognize the different stages of AFib including the pre-detection period

  Recognize patients who could benefit from non-pharmacologic options such as catheter ablation

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1137052

  Universal Activity Number

  Pharmacist 0798-0000-23-314-H01-P
  Nurse 0798-0000-23-314-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).